#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Astrocytoma malignant Human papilloma virus immunisation Congenital hypotransferrinaemia Hypophosphatasia Primary immunodeficiency syndrome Thermal burn Sarcoidosis Pseudomyxoma peritonei Alternating hemiplegia of childhood Non-small cell lung cancer Renal cancer metastatic Macular telangiectasia Heart disease congenital Hereditary hypophosphataemic rickets Arterial tortuosity syndrome More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Basic Information Pemphigoid – Trials in Disease Castleman’s disease – Treatment Soft tissue sarcoma – Life with Disease Glomerulonephritis rapidly progressive – Life with Disease Noonan syndrome – Diagnostics Angelman’s syndrome – Treatment Glycogen storage disease type V – Treatment Mitochondrial myopathy – Treatment Lennox-Gastaut syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fexofenadine Hydrochloride Mva-209-Fsp-B2 Danazol Phenol, Liquefied AUROCELL-TX Atorvastatin Eptacog Alfa (Activated) Isosorbide Dinitrate R-Azasetron Besilate Gsk4532990A Cemiplimab Mebendazole Anhydrous Docetaxel Nazartinib Warfarin Sodium PEGVISOMANT Gad20-209-Fsp-A1 ANTI-GD2-800CW Leniolisib Phosphate Goserelin Acetate More therapies…

    Learn about Your Condition

    Head injury Bronchiolitis Liposarcoma recurrent Rectal cancer stage II Hyperchylomicronaemia Biliary cancer metastatic Neuroblastoma Dizziness Paraganglion neoplasm Endocarditis enterococcal BK virus infection Lichenoid keratosis Ligament sprain Mantle cell lymphoma recurrent Metastases to biliary tract More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Major depression

  • A study of ketamine hydrochloride as an additional treatment for patients starting standard antidepressants for major depression

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    Sweden

  • A study to compare the safety of ketamine hydrochloride and esketamine in healthy men for the treatment of depression

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    • Esketamine Hydrochloride
    Germany

  • Testing Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Ulotaront
    • Citalopram
    • Venlafaxine
    Bulgaria Czechia Germany Hungary Poland Spain

  • Study on the Effects of Venlafaxine and Gut Microbiome in Patients with Major Depressive Disorder

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Venlafaxine
    The Netherlands

  • Study on Stopping Antidepressants: Comparing Tapering Methods for Patients with Major Depressive Disorder Using Venlafaxine or Paroxetine Hydrochloride

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Paroxetine Hydrochloride
    • Venlafaxine
    The Netherlands

  • Study on the Effectiveness and Safety of Intranasal BPL-003 for Patients with Treatment-Resistant Depression

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    Germany Poland Spain
Previous Page
1 … 5 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!